Pol Boudes

Overview

Pol Boudes received an average of $1M in total compensation, including $365K in salary, at Cymabay Therapeutics from 2014 to 2019.

Related executives

We found nine more executives who work or worked at Cymabay Therapeutics.

Sujal Shah

Cymabay Therapeutics

Chief Executive Officer

Charles McWherter

Cymabay Therapeutics

President of R&D

Paul Quinlan

Cymabay Therapeutics

General Counsel

Dennis Kim

Cymabay Therapeutics

Chief Medical Officer

Lewis Stuart

Cymabay Therapeutics

Chief Commercial Officer

Janet Dorling

Cymabay Therapeutics

Former Chief Commercial Officer

Klara Dickinson

Cymabay Therapeutics

Chief Regulatory and Compliance Officer

Daniel Menold

Cymabay Therapeutics

Vice President, Finance

News

You may also like